Skip to main content

CORRECTION article

Front. Neurol., 01 December 2022
Sec. Neuro-Oncology and Neurosurgical Oncology
Volume 13 - 2022 | https://doi.org/10.3389/fneur.2022.1084412

Corrigendum: Editorial: Quality of care of glioma patients

\nMarie-Therese Forster Marie-Therese Forster1*Philip De Witt HamerPhilip De Witt Hamer2Shawn L. Hervey-JumperShawn L. Hervey-Jumper3Mirjam Renovanz,,Mirjam Renovanz4,5,6
  • 1Department of Neurosurgery, University Hospital Frankfurt, Frankfurt, Germany
  • 2Department of Neurosurgery, Neurosurgical Center Amsterdam, Amsterdam, Netherlands
  • 3Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, United States
  • 4Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard-Karls University of Tübingen, Tübingen, Germany
  • 5Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital of Tuebingen, Eberhard Karls University of Tübingen, Tübingen, Germany
  • 6Department of Neurosurgery, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany

A corrigendum on
Editorial: Quality of care of glioma patients

by Forster, M. -T., De Witt Hamer, P., Hervey-Jumper, S. L., and Renovanz, M. (2022). Front. Neurol. 13:1041388. doi: 10.3389/fneur.2022.1041388

In the published article, there was an error regarding the affiliations for “Mirjam Renovanz.” Mirjam Renovanz's affiliations should be:

“4 Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard-Karls University of Tübingen, Tübingen, Germany

5 Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital of Tuebingen, Eberhard Karls University of Tübingen, Tübingen, Germany

6 Department of Neurosurgery, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: quality of care, glioma, quality of life, neurocognition, new technologies

Citation: Forster M-T, De Witt Hamer P, Hervey-Jumper SL and Renovanz M (2022) Corrigendum: Editorial: Quality of care of glioma patients. Front. Neurol. 13:1084412. doi: 10.3389/fneur.2022.1084412

Received: 30 October 2022; Accepted: 18 November 2022;
Published: 01 December 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Forster, De Witt Hamer, Hervey-Jumper and Renovanz. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Marie-Therese Forster, TWFyaWUtVGhlcmVzZS5Gb3JzdGVyJiN4MDAwNDA7bWVkLnVuaS1mcmFua2Z1cnQuZGU=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.